平成26年5月8日（木）開催分
Contents
1. a PCI 32765 2013 048 brutinib a YHI 1001 2013 053 Resminostat RO5304020 6 Trastuzumab Emtansine T DM1 a CC 5013 2013 067 1enalidomide 2013 069 3 o a SKI 606 IY Bosutinib 2009 043 1 S 1 2009 043 2 GSK1841157 2010 092 Ofatumumab BMS 901608 2011 0501 Elotuzumab BMS 901608 2011 050 2 Elotuzumab LY2127399 i Tabalumab LY2439821 2011 0901 lxekizumab E2. BI 3 023 2013 041 Fibrinogen Concentrate CSL uman FCH BI 3 023 2013 041 Fibrinogen Concentrate CSL B Human FCH 0 2013 060 R L F B 3mtans1ne T DM1 5 0 Meame wwwas 2 7 7
3. 1 Fo h 2012 010 2012 013 2012 025 2012 037 1 2012 037 2 2012 041 2012 060 2012 067 1 2012 067 2 2012 068 1 2012 068 2 2012 068 3 LY2439821 Ixekizumab AG 013736 Axitinib TAP 144 SR 6M TAP 144 SR 6M FPF300 Thalidomide GSK1841157 Ofatumumab AIN457 secukinumab LBH589 inosta LBH589 Panobinosta RO5072759 GA101 obinutuzuma BMS 650032 ASV BMS 790052 DCV DSP 1747 icholic acid SP 1747 icholic acid ONO 4538 BMS 936558 nivolumab ONO 4538 BMS 936558 nivolumab ONO 4538 BMS 936558 nivolumab
4. lt FTTT 4 wy TH 2013 008 7 TT 1 6 z 2 2013 017 Peg IFN Lambda 1a 8 DCV 2013 039 D390 Degarelix BI 3 023 2013 041 Fibrinogen Concentrate k CSL Human FCHI ON MLN9708 ixazomib citrate MLN9708 ixazomib citrate 12 2 5 7 18 2 3 3 3 2013 063 2013 065 2 2013 066 1 2 M 3 5 Y Resminostat CC 4047 Pomalidomide RO5304020 Trastuzumab Emtansine T DM1 ONO 705
5. 3 7 Y h
6. CRC CRC NN D lt 1 7 2009 043 ES JNJ 26866138 2009 076 Bortezomib 2012 013 2012 025 2012 060 2012 067 2012 070 2012 074 ASP1707 2012 083 GGS 2013 008 FPF3400 Na 20183 041 S 1 GSK1841157 Ofatumumab AIN457 secukinumab BMS 650032 ASV BMS 790052 DCV DSP 1747 Obeticholic acid L12500 L13000 L13500 L14000 SyB C 1101 Rigosertib FPF3400 S 914143 BMS 790052 FN Lambda 1a DCV BI 3 023 Fibrinogen Concentrate Hu
7. 4 7 h 4 3 VL gt KHK4827 eC A ER 2012 069 Brodalumab YR 5 2012 074 ASP1707 I 2012 075 MT 4666 3 5 20
8. 26 2 26 5 8 14 00 15 00 3 1 1 BMS 650032 ASV 2014 002 BMS 790052 DCV BMS 791325 2014 003 GS 7340 TAF 2014 004 GS 7340 TAF 2014 005 TAS 118 S 1 BAY 86 5321 2014 006 Afibercept 0 2014 507 2 E0302 o oo ee SKI 606 LEY Bosutinib C B ALS B 3 a
9. 12 075 5 W 1 2 2012 084 Telaprevir 2 3 5 1 ABI 007 Ak5 24 itaxel H 1 2 3 1 ABI 007 rTTT 3 rr y lt OED itaxel SGN 35 OL rentuximab Ve otin gt 1 2013 007 SN i I rentuximab ve otin SGN 35 9 8 5 gt a PA 1 i NN 20R 0 brentuximab vedotin 2 3 GGs
10. 7 Carfilzomib ONO 7057 Carfilzomib ONO 7057 Carfilzomib ONO 7057 Carfilzomib ONO 7057 Carfilzomib S 1 S 1 ARQ 197 tivantinib non GC B B DLBCL B B DLBCL 6 7 5
11. man FCHI 2 7 4 CsL
Download Pdf Manuals
Related Search